| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2015/05/06 | 16 : 28 | Analyst Ratings Network | Sarepta Therapeutics Upgraded to Outperform at Robert W. Baird (AVII) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/07/12 | 21 : 20 | Marketwired | Booming Biotechnology Industry Continues to Impress Investors in 2012 | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/07/12 | 19 : 50 | Marketwired | AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/07/11 | 19 : 04 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/07/07 | 05 : 05 | Marketwired | AVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/06/13 | 19 : 03 | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/06/06 | 05 : 08 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/06/02 | 06 : 28 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/06/02 | 05 : 30 | Marketwired | AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/11 | 22 : 59 | Marketwired | Potential Breakout Stock to Watch for 05/11/12: AVVC Issues News Release | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/11 | 05 : 14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/11 | 05 : 05 | Marketwired | AVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate Developments | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/10 | 22 : 04 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/04 | 21 : 20 | Marketwired | U.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to Benefit | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/04 | 17 : 14 | Zacks | Zacks #1 Rank Additions for Friday - Tale of the Tape | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/03 | 21 : 30 | Marketwired | AVI BioPharma Announces First Quarter 2012 Financial Results and Corporate Update Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/02 | 17 : 14 | Zacks | Zacks #1 Rank Additions for Wednesday - Tale of the Tape | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/05/01 | 05 : 34 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/26 | 06 : 26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/26 | 06 : 25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/26 | 06 : 21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/26 | 06 : 05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/25 | 21 : 30 | Marketwired | AVI BioPharma to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystro... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/20 | 23 : 10 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/13 | 05 : 33 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/02 | 22 : 12 | Dow Jones News | US STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/02 | 21 : 07 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/04/02 | 20 : 00 | Marketwired | AVI BioPharma Announces Eteplirsen Meets Primary Endpoint, Demonstrating a Significant Increase in Dystrophin at 24 Weeks Com... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/03/31 | 09 : 00 | Marketwired | AVI BioPharma Announces Conference Call and Webcast on Monday, April 2, 2012, to Discuss Top-Line Data Results From the Phase... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 2012/03/30 | 21 : 30 | Marketwired | Data From AVI BioPharma's Infectious Disease Programs to Be Presented at the 22nd European Congress of Clinical Microbiology ... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |